Ryan Specialty Holdings, Inc. (RYAN) · Oct 29, 2026 · Earnings
In line — Adjusted EPS $0.51 vs ~$0.49 consensus; revenue $790.0M vs ~$793.6M
Ryan Specialty’s third-quarter earnings slightly beat consensus, but slower organic growth, softer margins and a modestly lower outlook temper the result.
Ryan Specialty is navigating a softer specialty-insurance market while using its Empower restructuring program to streamline operations and invest in technology, AI, data and talent. Its core model remains focused on wholesale brokerage and underwriting management in specialty and excess-and-surplus insurance, where property pricing has weakened but casualty demand remains more supportive.
The quarter was broadly in line, not a clean beat. Adjusted diluted EPS of $0.51 exceeded the published consensus of roughly $0.49, but revenue of $790.0 million came in slightly below expectations near $793.6 million. That makes the headline earnings beat less meaningful: the business grew, but not quite as quickly as the market expected.
| Metric | Q3 2026 | Q3 2025 | Consensus |
|---|---|---|---|
| Total revenue (Financial Highlights) | $790.0M (+4.7%) | $754.6M | ~$793.6M |
| Organic revenue growth (Financial Highlights) | 4.0% | 15.0% | |
| Adjusted diluted EPS (Financial Highlights) | $0.51 (+8.5%) | $0.47 | ~$0.49 |
| Adjusted EBITDAC margin (Financial Highlights) | 30.9% | 31.2% |
Organic growth is the main pressure point. Revenue growth was driven by client wins, retention and specialty-market demand, but organic growth slowed sharply to 4.0% from 15.0% a year earlier. The company also said casualty growth was offset by a moderate property decline, showing that the market softening is now visible in the operating data. 〔0〕
Expense control protected earnings, but did not fully protect operating quality. Total operating expenses rose only 0.8%, helping GAAP net income increase 40.6%; however, adjusted EBITDAC grew just 3.8% and its margin declined 30 basis points. Compensation costs remain elevated as Ryan Specialty absorbs investment and restructuring spending under Empower.
Management preserved the growth framework but acknowledged less margin leverage. Full-year organic revenue guidance remains in the mid-single digits, while adjusted EBITDAC margin is now expected to be modestly lower than the prior year. That is not a collapse in the outlook, but it confirms that near-term efficiency gains are being used to offset slower market growth rather than expand margins. 〔1〕
Capital returns are supportive but do not change the operating story. Ryan Specialty repurchased $150 million of stock during the quarter and declared its regular $0.13 dividend; the buybacks helped adjusted EPS outperform the underlying revenue result, while debt remained material at $3.7 billion.
Bottom line: This is a mixed quarter: EPS beat because cost control and buybacks helped, but organic growth slowed and margins weakened. The filing keeps the business on track for mid-single-digit growth, while making clear that the market and the transition are limiting near-term operating leverage.
Q4 earnings report, early February 2027
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!